Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Sep;55(9):1217-21.
doi: 10.1136/gut.2005.090514.

Proton pump inhibitors and gastric neoplasia

E J Kuipers  1
Affiliations

Proton pump inhibitors and gastric neoplasia

E J Kuipers. Gut. 2006 Sep.

Abstract

Proton pump inhibitors (PPIs) are very effective in maintaining symptomatic and endoscopic remission of acid peptic disorders, such as gastro-oesophageal reflux disease. Side effects with respect to function and morphology of the gastric mucosa are common. Helicobacter pylori eradication can partially prevent and reverse these effects without impairing PPI therapy for gastro-oesophageal reflux disease. This makes long term PPI treatment a safe therapy for patients with acid peptic disorders. The potential side effects of such therapy are discussed here.

PubMed Disclaimer

Comment in

References

    1. Thomson A B, Barkun A N, Armstrong D.et al The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment‐Prompt Endoscopy (CADET‐PE) study. Aliment Pharmacol Ther 2003171481–1491. - PubMed
    1. van Soest E M, Dieleman J P, Siersema P D.et al Increasing incidence of Barrett's oesophagus in the general population. Gut 2005541062–1066. - PMC - PubMed
    1. van Soest E M, Siersema P D, Dieleman J P.et al Persistence and adherence to proton pump inhibitors in daily clinical practice. Aliment Pharmacol Ther 2006. (in press) - PubMed
    1. Abraham N S, El‐Serag H B, Johnson M L.et al National adherence to evidence‐based guidelines for the prescription of nonsteroidal anti‐inflammatory drugs. Gastroenterology 20051291171–1178. - PubMed
    1. Sturkenboom M C, Burke T A, Dieleman J P.et al Underutilization of preventive strategies in patients receiving NSAIDs. Rheumatology (Oxford) 200342(suppl 3)iii23–iii31. - PubMed

MeSH terms